Novel antibiotic substance from the human nose

- EN - DE
Novel antibiotic substance from the human nose
Researchers at the University of Tübingen have discovered a novel antibiotic substance from the human nose that can be used against pathogenic bacteria. Named epifadin, the molecule is produced from specific strains of the bacterial species Staphylococcus epidermidis, which occur on the mucous membrane of the inside wall of the nose. Strains that produce epifadin can also be isolated on the surface of the skin. Epifadin constitutes a new, previously unknown class of antimicrobial compounds that kills microorganisms and could be used as a lead structure for the development of novel antibiotics.

The human nose, skin and intestine are colonized by both benign and pathogenic bacteria. These microorganisms live together in what are called microbiomes. ...
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.